LONDON — Europe's medicines regulator found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues — though it said the ...

As of March 30, three deaths in people who experienced a combination of blood clotting, low platelet count and hemorrhaging three to 14 days after receiving the vaccine were reported in Norway, the ...

ZURICH (Reuters) - U.S. regulators have recommended pausing the use of Johnson & Johnson's COVID-19 vaccine as they investigate rare blood clotting in six women, including one who died. J&J also said ...

As countries in Europe and elsewhere continue to pause administration of the AstraZeneca COVID-19 vaccines over reports of clotting events in recipients, the European Medicines Agency (EMA) announced ...

LONDON — For months, European countries have seesawed between craving and rebuffing AstraZeneca’s vaccine, with the shot’s fortunes rising and falling on spats over supply and on questions over the ...

OSLO (Reuters) - Three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine are being treated in hospital for bleeding, blood clots and a low count of blood platelets, ...